Lisa Gill
Stock Analyst at JP Morgan
(3.18)
# 1,101
Out of 5,148 analysts
139
Total ratings
47.87%
Success rate
1.6%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GDRX GoodRx Holdings | Downgrades: Neutral | n/a | $2.17 | - | 3 | Feb 27, 2026 | |
| LH Labcorp Holdings | Maintains: Overweight | $319 → $330 | $286.47 | +15.20% | 4 | Feb 18, 2026 | |
| CAH Cardinal Health | Maintains: Neutral | $209 → $243 | $229.88 | +5.71% | 7 | Feb 10, 2026 | |
| COR Cencora | Maintains: Overweight | $417 → $419 | $372.65 | +12.44% | 4 | Feb 10, 2026 | |
| MCK McKesson | Maintains: Overweight | $983 → $1,107 | $990.95 | +11.71% | 15 | Feb 10, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $394 → $397 | $294.07 | +35.00% | 7 | Feb 2, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $425 → $389 | $294.93 | +31.90% | 11 | Feb 2, 2026 | |
| MDLN Medline | Initiates: Overweight | $50 | $45.85 | +9.05% | 1 | Jan 12, 2026 | |
| CVS CVS Health | Maintains: Overweight | $93 → $101 | $81.66 | +23.68% | 6 | Dec 17, 2025 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $20 → $23 | $19.65 | +17.05% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $32 → $33 | $24.04 | +37.27% | 6 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $26 | $17.60 | +47.73% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $428 → $375 | $290.85 | +28.93% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $7.43 | +34.59% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $210.25 | -9.63% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $23.72 | +26.48% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $31.60 | +29.75% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $187.28 | +36.69% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $37.80 | -52.38% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $9.27 | -46.06% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $15.88 | +76.32% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $5.16 | +74.42% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $9.48 | +89.87% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $152.42 | +159.15% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $206.42 | -9.89% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $235.12 | -40.46% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $532.92 | -37.70% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $0.62 | +1,362.23% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.14 | +12.04% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $81.37 | +2.00% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $44.60 | +119.73% | 1 | Jan 6, 2023 |
GoodRx Holdings
Feb 27, 2026
Downgrades: Neutral
Price Target: n/a
Current: $2.17
Upside: -
Labcorp Holdings
Feb 18, 2026
Maintains: Overweight
Price Target: $319 → $330
Current: $286.47
Upside: +15.20%
Cardinal Health
Feb 10, 2026
Maintains: Neutral
Price Target: $209 → $243
Current: $229.88
Upside: +5.71%
Cencora
Feb 10, 2026
Maintains: Overweight
Price Target: $417 → $419
Current: $372.65
Upside: +12.44%
McKesson
Feb 10, 2026
Maintains: Overweight
Price Target: $983 → $1,107
Current: $990.95
Upside: +11.71%
Elevance Health
Feb 2, 2026
Maintains: Overweight
Price Target: $394 → $397
Current: $294.07
Upside: +35.00%
UnitedHealth Group
Feb 2, 2026
Maintains: Overweight
Price Target: $425 → $389
Current: $294.93
Upside: +31.90%
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $45.85
Upside: +9.05%
CVS Health
Dec 17, 2025
Maintains: Overweight
Price Target: $93 → $101
Current: $81.66
Upside: +23.68%
Alignment Healthcare
Dec 17, 2025
Maintains: Overweight
Price Target: $20 → $23
Current: $19.65
Upside: +17.05%
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $24.04
Upside: +37.27%
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $17.60
Upside: +47.73%
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $290.85
Upside: +28.93%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $7.43
Upside: +34.59%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $210.25
Upside: -9.63%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $23.72
Upside: +26.48%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $31.60
Upside: +29.75%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $187.28
Upside: +36.69%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $37.80
Upside: -52.38%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $9.27
Upside: -46.06%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $15.88
Upside: +76.32%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $5.16
Upside: +74.42%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $9.48
Upside: +89.87%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $152.42
Upside: +159.15%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $206.42
Upside: -9.89%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $235.12
Upside: -40.46%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $532.92
Upside: -37.70%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $0.62
Upside: +1,362.23%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.14
Upside: +12.04%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $81.37
Upside: +2.00%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $44.60
Upside: +119.73%